Divergent Resorbability and Effects on Osteoclast Formation of Commonly Used Bone Substitutes in a Human In Vitro-Assay

Bioactive bone substitute materials are a valuable alternative to autologous bone transplantations in the repair of skeletal defects. However, clinical studies have reported varying success rates for many commonly used biomaterials. While osteoblasts have traditionally been regarded as key players mediating osseointegration, increasing evidence suggests that bone-resorbing osteoclasts are of crucial importance for the longevity of applied biomaterials. As no standardized data on the resorbability of biomaterials exists, we applied an in vitro-assay to compare ten commonly used bone substitutes. Human peripheral blood mononuclear cells (PBMCs) were differentiated into osteoclasts in the co-presence of dentin chips and biomaterials or dentin alone (control) for a period of 28 days. Osteoclast maturation was monitored on day 0 and 14 by light microscopy, and material-dependent changes in extracellular pH were assessed twice weekly. Mature osteoclasts were quantified using TRAP stainings on day 28 and their resorptive activity was determined on dentin (toluidin blue staining) and biomaterials (scanning electron microscopy, SEM). The analyzed biomaterials caused specific changes in the pH, which were correlated with osteoclast multinuclearity (r = 0.942; p = 0.034) and activity on biomaterials (r = 0.594; p = 0.041). Perossal led to a significant reduction of pH, nuclei per osteoclast and dentin resorption, whereas Tutogen bovine and Tutobone human strikingly increased all three parameters. Furthermore, natural biomaterials were resorbed more rapidly than synthetic biomaterials leading to differential relative resorption coefficients, which indicate whether bone substitutes lead to a balanced resorption or preferential resorption of either the biomaterial or the surrounding bone. Taken together, this study for the first time compares the effects of widely used biomaterials on osteoclast formation and resorbability in an unbiased approach that may now aid in improving the preclinical evaluation of bone substitute materials.

[1]  Greer Rb rd Wolff's Law. , 1993 .

[2]  D. Sohn,et al.  A Method of Sealing Perforated Sinus Membrane and Histologic Finding of Bone Substitutes: A Case Report , 2005, Implant dentistry.

[3]  K. Aoki,et al.  Three-dimensional characterization of osteoclast bone-resorbing activity in the resorption lacunae. , 2009, Journal of medical and dental sciences.

[4]  R E Booth,et al.  Harvesting Autogenous Iliac Bone Grafts: A Review of Complications and Techniques , 1989, Spine.

[5]  R C Edwards,et al.  The fate of resorbable poly-L-lactic/polyglycolic acid (LactoSorb) bone fixation devices in orthognathic surgery. , 2001, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[6]  T. Uemura,et al.  Laser microscopic measurement of osteoclastic resorption pits on biomaterials , 2007 .

[7]  S. J. Jones,et al.  The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro , 1992, Anatomy and Embryology.

[8]  M. Raška,et al.  Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. , 2008, Physiological research.

[9]  T. Gotterbarm,et al.  The efficacy of Biobon™ and Ostim™ within metaphyseal defects using the Göttinger Minipig , 2009, Archives of Orthopaedic and Trauma Surgery.

[10]  J. Risteli,et al.  Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts. , 2001, Endocrinology.

[11]  W. Linhart,et al.  [Treatment of metaphyseal bone defects after fractures of the distal radius. Medium-term results using a calcium-phosphate cement (BIOBON)]. , 2003, Der Unfallchirurg.

[12]  M. Reinhold,et al.  Successful posterior interlaminar fusion at the thoracic spine by sole use of β-tricalcium phosphate , 2006, Archives of Orthopaedic and Trauma Surgery.

[13]  S. Meyer,et al.  Histological osseointegration of Tutobone®: first results in human , 2008, Archives of Orthopaedic and Trauma Surgery.

[14]  D. Weerakoon SAFTA: Current Status and Prospects , 2010 .

[15]  M. Rauschmann,et al.  Effectiveness of Combination Use of Antibiotic-Loaded PerOssal® with Spinal Surgery in Patients with Spondylodiscitis , 2009, European Surgical Research.

[16]  A. Rack,et al.  Effect of beta-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans. , 2008, Biomaterials.

[17]  T. Bauer,et al.  Bone graft substitutes , 2007, Skeletal Radiology.

[18]  D. Williams,et al.  Immune response in biocompatibility. , 1992, Biomaterials.

[19]  J. David,et al.  TNF and bone. , 2010, Current directions in autoimmunity.

[20]  J. Heersche,et al.  Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  E. Nkenke,et al.  Bone regeneration in osseous defects-application of particulated human and bovine materials. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[22]  J. Jansen,et al.  Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone. , 2003, Biomaterials.

[23]  P. Buma,et al.  Mechanism of bone incorporation of beta-TCP bone substitute in open wedge tibial osteotomy in patients. , 2005, Biomaterials.

[24]  J. V. D. van den Bergh,et al.  Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. , 2005, The International journal of oral & maxillofacial implants.

[25]  R. Sader,et al.  Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb) for bone regeneration in the reconstructive surgery of the jaws. , 2006, International journal of oral and maxillofacial surgery.

[26]  M. Morlock,et al.  Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro. , 2009, Biomaterials.

[27]  T. Lange,et al.  Size dependent induction of proinflammatory cytokines and cytotoxicity of particulate beta-tricalciumphosphate in vitro. , 2011, Biomaterials.

[28]  Rueger Jm Bone substitution materials. Current status and prospects , 1998 .

[29]  A. Horvai,et al.  Metabolic bone diseases. , 2011, Seminars in diagnostic pathology.

[30]  C. Ruff,et al.  Who's afraid of the big bad Wolff?: "Wolff's law" and bone functional adaptation. , 2006, American journal of physical anthropology.

[31]  P. Meeder,et al.  Minimally Invasive Reduction and Internal Stabilization of Osteoporotic Vertebral Body Fractures (Balloon Kyphoplasty) , 2005, European Journal of Trauma.

[32]  Matthias Epple,et al.  Biological and medical significance of calcium phosphates. , 2002, Angewandte Chemie.

[33]  T. Miclau,et al.  Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? , 2007, Injury.

[34]  W. Tomford,et al.  Transmission of disease through transplantation of musculoskeletal allografts. , 1995, The Journal of bone and joint surgery. American volume.

[35]  O. Kilian,et al.  Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[36]  J. Rueger [Bone substitution materials. Current status and prospects]. , 1998, Der Orthopade.

[37]  Ann M. Trousdale Who's afraid of the big, bad wolf? , 1989 .

[38]  A. Schilling,et al.  Resorbability of bone substitute biomaterials by human osteoclasts. , 2004, Biomaterials.

[39]  P. Heini,et al.  Bone substitutes in vertebroplasty , 2001, European Spine Journal.